title: Editorial: fenofibrate as second-line therapy in high risk PBC--more answers or more questions?
authors: Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK. david.jones@ncl.ac.uk.
authors: D E J
authors: DE
authors: Jones
authors: Epidemiology & Biostatistics, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
authors: B E
authors: BE
authors: Hansen
mesh_terms: D005260:Female; D011345:Fenofibrate / Q000008:administration & dosage*; D006801:Humans; D008105:Liver Cirrhosis, Biliary / Q000188:drug therapy*; D008297:Male; D014580:Ursodeoxycholic Acid / Q000008:administration & dosage*
chemical_list: D014580:Ursodeoxycholic Acid; D011345:Fenofibrate